boc‐mlf Search Results


boc-mlf tfa  (TargetMol)
N/A
   Buy from Supplier
boc-mlf  (MedChemExpress)
N/A
Boc-MLF (TFA) is a peptide, used as a specific formyl peptide receptor (FPR) antagonist, also inhibits the signaling through formyl peptide receptor like 1 (FPRL1) at higher concentrations.
   Buy from Supplier
boc mlf  (Tocris)
94
Tocris boc mlf
Boc Mlf, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/boc%E2%80%90mlf/pmc05912276-57-6-7?v=Tocris
Average 94 stars, based on 1 article reviews
boc mlf - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
wrw4  (Tocris)
93
Tocris wrw4
(A) The effect of FPRa14 (0–10μM) on the percentage differentiation of N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. (B) The effect of FPRa14 (10μM) on the proportion of the differentiated cell morphology types following Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. N2a cells were also transfected with a negative control siRNA duplex as a control. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to appropriate negative control siRNA (n = 1120). (C) The effect of FPRa14 (8μM) on the % of differentiated N2a cells after 30min incubation with Boc-MLF (0–40μM), cyclosporin H (0–40μM) or <t>WRW4</t> (0–40μM). Serum-free medium only (SFM) was used as a negative control (n = 1121). (D) The effect of Boc-MLF only (40μM), cyclosporin H only (40μM), WRW4 only (40μM) and SFM on the % of differentiated N2a cells (n = 355). Values are mean ±SEM, taken after 48h of incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to serum-free medium control.
Wrw4, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/boc%E2%80%90mlf/pmc06553754-45-3-7?v=Tocris
Average 93 stars, based on 1 article reviews
wrw4 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
n tert butyloxycarbonyl lmethionyl l leucyl l phenylalanine  (BOC Sciences)
90
BOC Sciences n tert butyloxycarbonyl lmethionyl l leucyl l phenylalanine
(A) The effect of FPRa14 (0–10μM) on the percentage differentiation of N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. (B) The effect of FPRa14 (10μM) on the proportion of the differentiated cell morphology types following Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. N2a cells were also transfected with a negative control siRNA duplex as a control. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to appropriate negative control siRNA (n = 1120). (C) The effect of FPRa14 (8μM) on the % of differentiated N2a cells after 30min incubation with Boc-MLF (0–40μM), cyclosporin H (0–40μM) or <t>WRW4</t> (0–40μM). Serum-free medium only (SFM) was used as a negative control (n = 1121). (D) The effect of Boc-MLF only (40μM), cyclosporin H only (40μM), WRW4 only (40μM) and SFM on the % of differentiated N2a cells (n = 355). Values are mean ±SEM, taken after 48h of incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to serum-free medium control.
N Tert Butyloxycarbonyl Lmethionyl L Leucyl L Phenylalanine, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/boc%E2%80%90mlf/pm11509634-40-22-23?v=BOC+Sciences
Average 90 stars, based on 1 article reviews
n tert butyloxycarbonyl lmethionyl l leucyl l phenylalanine - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
boc mlf  (GlpBio Technology Inc)
90
GlpBio Technology Inc boc mlf
(A) The effect of FPRa14 (0–10μM) on the percentage differentiation of N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. (B) The effect of FPRa14 (10μM) on the proportion of the differentiated cell morphology types following Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. N2a cells were also transfected with a negative control siRNA duplex as a control. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to appropriate negative control siRNA (n = 1120). (C) The effect of FPRa14 (8μM) on the % of differentiated N2a cells after 30min incubation with Boc-MLF (0–40μM), cyclosporin H (0–40μM) or <t>WRW4</t> (0–40μM). Serum-free medium only (SFM) was used as a negative control (n = 1121). (D) The effect of Boc-MLF only (40μM), cyclosporin H only (40μM), WRW4 only (40μM) and SFM on the % of differentiated N2a cells (n = 355). Values are mean ±SEM, taken after 48h of incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to serum-free medium control.
Boc Mlf, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/boc%E2%80%90mlf/pmc11659116-61-3-7?v=GlpBio+Technology+Inc
Average 90 stars, based on 1 article reviews
boc mlf - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
n-t-butoxycarbonyl-l-methionyl-l-leucyl-l-phenylalanine (n-t-boc-mlf  (Becton Dickinson)
90
Becton Dickinson n-t-butoxycarbonyl-l-methionyl-l-leucyl-l-phenylalanine (n-t-boc-mlf
(A) The effect of FPRa14 (0–10μM) on the percentage differentiation of N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. (B) The effect of FPRa14 (10μM) on the proportion of the differentiated cell morphology types following Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. N2a cells were also transfected with a negative control siRNA duplex as a control. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to appropriate negative control siRNA (n = 1120). (C) The effect of FPRa14 (8μM) on the % of differentiated N2a cells after 30min incubation with Boc-MLF (0–40μM), cyclosporin H (0–40μM) or <t>WRW4</t> (0–40μM). Serum-free medium only (SFM) was used as a negative control (n = 1121). (D) The effect of Boc-MLF only (40μM), cyclosporin H only (40μM), WRW4 only (40μM) and SFM on the % of differentiated N2a cells (n = 355). Values are mean ±SEM, taken after 48h of incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to serum-free medium control.
N T Butoxycarbonyl L Methionyl L Leucyl L Phenylalanine (N T Boc Mlf, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/boc%E2%80%90mlf/pm24880063-48-0-4?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
n-t-butoxycarbonyl-l-methionyl-l-leucyl-l-phenylalanine (n-t-boc-mlf - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
boc-mlf  (TargetMol)
N/A
   Buy from Supplier
boc-mlf tfa  (Aladdin Scientific Corporation)
N/A
Boc-MLF (TFA) is a peptide, used as a specific formyl peptide receptor (FPR) antagonist, also inhibits the signaling through formyl peptide receptor like 1 (FPRL1) at higher concentrations.Appearance:SolidIC50& Target:FPR/FPRL1In Vitro:Boc-MLF inhibits superoxide production induced by
   Buy from Supplier
boc-mlf  (Aladdin Scientific Corporation)
N/A
Solubility:Soluble to 2 mg/ml in DMSO
   Buy from Supplier

Image Search Results


(A) The effect of FPRa14 (0–10μM) on the percentage differentiation of N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. (B) The effect of FPRa14 (10μM) on the proportion of the differentiated cell morphology types following Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. N2a cells were also transfected with a negative control siRNA duplex as a control. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to appropriate negative control siRNA (n = 1120). (C) The effect of FPRa14 (8μM) on the % of differentiated N2a cells after 30min incubation with Boc-MLF (0–40μM), cyclosporin H (0–40μM) or WRW4 (0–40μM). Serum-free medium only (SFM) was used as a negative control (n = 1121). (D) The effect of Boc-MLF only (40μM), cyclosporin H only (40μM), WRW4 only (40μM) and SFM on the % of differentiated N2a cells (n = 355). Values are mean ±SEM, taken after 48h of incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to serum-free medium control.

Journal: PLoS ONE

Article Title: The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA

doi: 10.1371/journal.pone.0217815

Figure Lengend Snippet: (A) The effect of FPRa14 (0–10μM) on the percentage differentiation of N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. (B) The effect of FPRa14 (10μM) on the proportion of the differentiated cell morphology types following Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. N2a cells were also transfected with a negative control siRNA duplex as a control. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to appropriate negative control siRNA (n = 1120). (C) The effect of FPRa14 (8μM) on the % of differentiated N2a cells after 30min incubation with Boc-MLF (0–40μM), cyclosporin H (0–40μM) or WRW4 (0–40μM). Serum-free medium only (SFM) was used as a negative control (n = 1121). (D) The effect of Boc-MLF only (40μM), cyclosporin H only (40μM), WRW4 only (40μM) and SFM on the % of differentiated N2a cells (n = 355). Values are mean ±SEM, taken after 48h of incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to serum-free medium control.

Article Snippet: FPRa14, Boc-MLF and WRW4 were obtained from Tocris Bioscience (UK).

Techniques: Control, Transfection, Negative Control, Incubation

(A) The effect of FPRa14 (0-10mM) on % control MTT reduction in N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to negative control siRNA plus FPRa14. (B) The effect of FPRa14 (0-10mM) alone, FPRa14 (0-10mM) following 30min pre-incubation with Boc-MLF (40μM) or cyclosporin H (40μM) on N2a % control MTT reduction. (C) The effect of FPRa14 (0-10mM) alone and FPRa14 (0-10mM) following 30min pre-incubation with WRW4 (40μM) on N2a % control MTT reduction. Values are mean ±SEM from six repeats. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to positive FPRa14 control. (D) The effect of FPRa14 (10μM) alone or serum free media and FPRa14 (10μM) or serum free media following 30min pre-incubation with Boc-MLF (40μM), cyclosporin H (40μM) or WRW4 (40μM) on N2a % control MTT reduction. Values are mean ±SEM from six repeats. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to serum free media, # represents statistical significance (P<0.01) relative to FPRa14 (10μM).

Journal: PLoS ONE

Article Title: The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA

doi: 10.1371/journal.pone.0217815

Figure Lengend Snippet: (A) The effect of FPRa14 (0-10mM) on % control MTT reduction in N2a cells following control siRNA, Fpr1, Fpr2, and simultaneous Fpr1 & Fpr2 siRNA treatment. Values represent mean ±SEM, following 24h incubation with FPRa14. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to negative control siRNA plus FPRa14. (B) The effect of FPRa14 (0-10mM) alone, FPRa14 (0-10mM) following 30min pre-incubation with Boc-MLF (40μM) or cyclosporin H (40μM) on N2a % control MTT reduction. (C) The effect of FPRa14 (0-10mM) alone and FPRa14 (0-10mM) following 30min pre-incubation with WRW4 (40μM) on N2a % control MTT reduction. Values are mean ±SEM from six repeats. Statistical analysis was performed via one-way ANOVA with Dunnett’s post-hoc test. *Represents statistical significance (P<0.01) relative to positive FPRa14 control. (D) The effect of FPRa14 (10μM) alone or serum free media and FPRa14 (10μM) or serum free media following 30min pre-incubation with Boc-MLF (40μM), cyclosporin H (40μM) or WRW4 (40μM) on N2a % control MTT reduction. Values are mean ±SEM from six repeats. Statistical analysis was performed via one-way ANOVA with Dunnett’s post hoc test. *Represents statistical significance (P<0.01) relative to serum free media, # represents statistical significance (P<0.01) relative to FPRa14 (10μM).

Article Snippet: FPRa14, Boc-MLF and WRW4 were obtained from Tocris Bioscience (UK).

Techniques: Control, Incubation, Negative Control